Clinical Research Directory
Browse clinical research sites, groups, and studies.
Exercise and the Menstrual Cycle in Type 1 Diabetes
Sponsor: University of Alberta
Summary
Female participants with type 1 diabetes using oral contraceptives will be asked to wear a continuous glucose monitor for at least three days on two separate occasions (once during the last week of active pills and once during the no pill/placebo pill phase of the menstrual cycle). An exercise session (45 minutes of aerobic exercise at 60% VO2peak on a cycle ergometer) will take place at 5 pm on the second day of glucose monitoring.
Official title: Effects of the Menstrual Cycle on Blood Glucose Changes During Exercise in Women With Type 1 Diabetes Using Oral Contraceptives
Key Details
Gender
FEMALE
Age Range
18 Years - 50 Years
Study Type
INTERVENTIONAL
Enrollment
15
Start Date
2022-03-15
Completion Date
2026-08-30
Last Updated
2025-07-08
Healthy Volunteers
No
Conditions
Interventions
Luteal Phase Aerobic Exercise
Participants will perform 45 minutes of moderate (60% VO2peak) aerobic exercise on a cycle ergometer during the last week of active pill consumption.
Follicular Phase Aerobic Exercise
Participants will perform 45 minutes of moderate (60% VO2peak) aerobic exercise on a cycle ergometer within 5 days of starting their menses.
Locations (1)
Alberta Diabetes Institute
Edmonton, Alberta, Canada